Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Behavioral Weight Loss Therapy for Obesity and Binge Eating in Monolingual Hispanic Persons
This study is currently recruiting participants.
Study NCT00516919   Information provided by Yale University
First Received: August 15, 2007   Last Updated: July 6, 2009   History of Changes

August 15, 2007
July 6, 2009
August 2007
December 2010   (final data collection date for primary outcome measure)
Body weight / BMI [ Time Frame: 4 months and 6 month follow-up ] [ Designated as safety issue: No ]
Body weight / BMI [ Time Frame: 4 months and 6 month follow-up ]
Complete list of historical versions of study NCT00516919 on ClinicalTrials.gov Archive Site
 
 
 
Study of Behavioral Weight Loss Therapy for Obesity and Binge Eating in Monolingual Hispanic Persons
Controlled Trial of Orlistat With Behavioral Weight Loss Therapy for Obesity and Binge Eating in Monolingual Hispanic Persons

This is a research study designed to examine the effectiveness of an obesity medication (orlistat) given in addition to behavioral weight loss therapy. Participants will be obese monolingual (Spanish-speaking only) men and women.

 
Phase IV
Interventional
Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment, Efficacy Study
  • Obesity
  • Binge Eating
  • Drug: Xenical + behavioral intervention
  • Behavioral: Behavioral intervention + placebo
  • Experimental: Xenical + behavioral intervention
  • Active Comparator: Placebo + behavioral intervention
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
80
 
December 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Monolingual Spanish Speaking
  • Obese (BMI >= 30)

Exclusion Criteria:

  • Pregnancy
  • Current cardiac disease
  • Serious neurologic illnesses
Both
18 Years to 60 Years
Yes
Contact: Luis M Anez, PsyD 203-789-7812 Luis.Aneznava@yale.edu
Contact: Manuel Paris, PsyD 203-789-7812 Manuel.Paris@yale.edu
United States
 
NCT00516919
Carlos M. Grilo, PhD, Yale University School of Medicine
DF-06-018
Yale University
Donaghue Medical Research Foundation
Principal Investigator: Carlos M Grilo, PhD Yale University
Yale University
July 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP